Executives made the case to investors that the company’s whole-person virtual care products will beat the competition in a crowded market.
Teladoc raises revenue guidance after beating Wall Street expectations in Q2 Read More »
The former employee of B. Braun’s Aesculap division admitted creating the letters on FDA letterhead and forging an agency official’s digital signature.
Regulatory specialist pleads guilty to forging FDA clearance letters Read More »
Un método mediado por protones que produce múltiples transiciones de fase en materiales ferroeléctricos podría ayudar a desarrollar dispositivos de memoria de alto rendimiento, incluyendo chips de ordenador neuromórficos, o sea inspirados en el cerebro humano. &nb …
Nueva generación de dispositivos de memoria basados en el protón Read More »
Soin Neuroscience has announced that it has tested its TunedTX platform using very low frequency stimulation.
Soin Neuroscience Tests Very Low Frequency Spinal Cord Stimulation in Humans Read More »
Organicell Regenerative Medicine, Inc . today reported the results of its Phase 1/2A research program for its biologic therapeutic, Zofin TM , which contains high concentrations of nanoparticles, including exosomes, growth factors, and bio-active proteins.
Organicell Reports Interim Results of Phase 1/2A Research Program Read More »
MyoPax has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for its regenerative cell therapy in Exstrophy-Epispadias Complex (EEC).
Cybin Inc. today announced that it has partnered with Worldwide Clinical Trials (“Worldwide”), a global, full-service contract research organization (“CRO”) with deep expertise managing clinical trials for mental health conditions, including major depressive disorder.
Lymph nodes are one of the body’s first lines of defense against disease. Immune cells are dispatched from these biological police stations to fight off intruders. But somehow, lymph nodes are also the first stop for most metastatic cancers.
Fortive Corporation today announced financial results for the second quarter 2023.
Fortive Reports Strong Second Quarter 2023 Results; Raises Full Year 2023 Outlook Read More »
ViroCell Biologics, a specialist Contract Development and Manufacturing Organisation in cell and gene therapy clinical trials, announces the appointment of Brian Collins as Chief Financial Officer.
